Behçet's disease classification
|
Behçet's disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Behçet's disease classification On the Web |
|
American Roentgen Ray Society Images of Behçet's disease classification |
|
Risk calculators and risk factors for Behçet's disease classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]
Overview
Classification
Neurologic disease
- Neurologic disease of Behcet disease is classified into parenchymal or non-parenchymal
Parenchymal disease
- Parenchymal disease is due to lesions in the corticospinal tract, brainstem, periventricular white matter, spinal cord, and basal ganglia.
- Brainstem disease (which may extend to the midbrain, basal ganglia, and diencephalon) including focal lesions or atrophy with signs and symptoms including ophthalmoparesis, cranial neuropathy, and cerebellar or pyramidal dysfunction are more characteristic of Behçet syndrome than multiple sclerosis.
- Cerebral lesions are often multiple though may be single, are often subcortical, and are not particularly peri-ventricular, as in multiple sclerosis.
- Spinal cord lesions (myelitis) may occur in isolation, but are more common in patients with other central nervous system lesions.
- The clinical presentation of parenchymal disease is often subacute and manifestations may include headache, behavior changes, and deficits reflecting areas of parenchymal involvement
- Focal parenchymal lesions and complications of vascular thrombosis are the most common abnormalities.
- Progressive personality change, psychiatric disorders, and dementia may develop.
- Unlike many other systemic vasculitic disorders, peripheral neuropathy is not a common in Behçet syndrome.[1][2][3]
- Parenchymal disease may be divided into acute and chronic progressive neuro-Behçet syndrome.
- A meta-analysis reviewed 184 acute and 114 chronic progressive cases, and fever and higher cerebrospinal fluid cell counts were found more commonly in acute disease, and sphincter disturbances, ataxia, confusion, brainstem atrophy on magnetic resonance imaging (MRI), and cerebral changes on MRI were more common in chronic progressive disease.[4]
- Central nervous system lesions are detectable with MRI.[5][6]
- Acute and subacute lesions are hypointense or isointense on T1-weighted images; hyperintense on T2-weighted, FLAIR, and diffusion-weighted images; and commonly enhance with contrast.
- In the chronic phase, lesions may be smaller or resolve, atrophy may be present, nonspecific white matter lesions may be present, and lesions usually do not enhance.
- Cerebrospinal fluid (CSF) may show increased protein and increased cells, and neutrophils may predominate.[7]
- Pathology reveals local perivenular lymphocytic cuffing, inflammatory cell infiltration, gliosis, necrosis, and neuronal loss. Although frank vasculitis is not always observed in parenchymal lesions, it is sometimes noted in larger cerebral vessels, including arteries or veins. Arteritis may lead to ischemic strokes, dissection, aneurysmal dilatation, and subarachnoid hemorrhage.
Non-parenchymal disease
Non-parenchymal disease of Behcet disease include the following:
- Cerebral venous thrombosis, intracranial hypertension syndrome (pseudotumor cerebri), acute meningeal syndrome, and uncommonly stroke due to arterial thrombosis, dissection, or aneurysm [55].
- Central nervous system manifestations may result from arterial or venous thrombosis, including dural sinus thrombosis.[8]
- Cerebral venous thrombosis may present with headache, papilledema, sixth nerve palsy, and an elevated CSF pressure [12,23,46,56-59].
- An association has been observed between dural sinus thrombosis and peripheral deep venous thrombosis [46].
- Thrombosis of the cerebral arteries may also be observed.[8]
46
- One analysis of neurologic Behçet syndrome from Turkey, involving 26 children and 702 adults, found that dural venous sinus thrombosis was much more common in children than parenchymal neurologic involvement, although parenchymal disease was more frequent in adults [22].
- In one large series, the clinical features and outcomes of 200 patients with Behçet syndrome and neurologic involvement were reported [46].
- On average, a period of approximately five to six years elapsed between the onset of the earliest non-neurologic symptoms of Behçet syndrome and the appearance of neurologic symptoms or findings.
- Nevertheless, neurologic findings may also appear concurrently (7.5 percent) or precede non-neurologic features (3 percent). Twenty percent of those with neurologic findings were asymptomatic.
References
- ↑ Atasoy HT, Tunc TO, Unal AE, Emre U, Koca R, Esturk E; et al. (2007). "Peripheral nervous system involvement in patients with Behçet disease". Neurologist. 13 (4): 225–30. doi:10.1097/NRL.0b013e31805778d1. PMID 17622917.
- ↑ Akbulut L, Gur G, Bodur H, Alli N, Borman P (2007). "Peripheral neuropathy in Behçet disease: an electroneurophysiological study". Clin Rheumatol. 26 (8): 1240–4. doi:10.1007/s10067-006-0466-0. PMID 17149536.
- ↑ Benamour S, Naji T, Alaoui FZ, El-Kabli H, El-Aidouni S (2006). "[Neurological involvement in Behçet's disease. 154 cases from a cohort of 925 patients and review of the literature]". Rev Neurol (Paris). 162 (11): 1084–90. PMID 17086145.
- ↑ Ishido M, Horita N, Takeuchi M, Shibuya E, Yamane T, Kawagoe T; et al. (2017). "Distinct clinical features between acute and chronic progressive parenchymal neuro-Behçet disease: meta-analysis". Sci Rep. 7 (1): 10196. doi:10.1038/s41598-017-09938-z. PMC 5579041. PMID 28860590.
- ↑ Akman-Demir G, Serdaroglu P, Tasçi B (1999). "Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group". Brain. 122 ( Pt 11): 2171–82. PMID 10545401.
- ↑ Lee SH, Yoon PH, Park SJ, Kim DI (2001). "MRI findings in neuro-behçet's disease". Clin Radiol. 56 (6): 485–94. doi:10.1053/crad.2000.0675. PMID 11428799.
- ↑ Kalra S, Silman A, Akman-Demir G, Bohlega S, Borhani-Haghighi A, Constantinescu CS; et al. (2014). "Diagnosis and management of Neuro-Behçet's disease: international consensus recommendations". J Neurol. 261 (9): 1662–76. doi:10.1007/s00415-013-7209-3. PMC 4155170. PMID 24366648.
- ↑ 8.0 8.1 Farah S, Al-Shubaili A, Montaser A, Hussein JM, Malaviya AN, Mukhtar M; et al. (1998). "Behçet's syndrome: a report of 41 patients with emphasis on neurological manifestations". J Neurol Neurosurg Psychiatry. 64 (3): 382–4. PMC 2169980. PMID 9527155.